According to Mesoblast 's latest financial reports the company's total assets are $0.66 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-06-30 | $0.66 B | 1.1% |
2022-06-30 | $0.66 B | -11.09% |
2021-06-30 | $0.74 B | 1.52% |
2020-06-30 | $0.73 B | 12.5% |
2019-06-30 | $0.65 B | -5.82% |
2018-06-30 | $0.69 B | 5.61% |
2017-06-30 | $0.65 B | -4.14% |
2016-06-30 | $0.68 B | -12.5% |
2015-06-30 | $0.78 B | -13.07% |
2014-06-30 | $0.89 B | 1.77% |
2013-06-30 | $0.88 B | 22.66% |
2012-06-30 | $0.72 B | -5.61% |
2011-06-30 | $0.76 B | 1831.56% |
2010-06-30 | $39.51 M | 46.49% |
2009-06-30 | $26.97 M | -2.93% |
2008-06-30 | $27.78 M | 30.84% |
2007-06-30 | $21.23 M | 29.13% |
2006-06-30 | $16.44 M | -23.38% |
2005-06-30 | $21.46 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $0.27 M | -99.96% | Bahamas |
NRC Health
NRC | $0.12 B | -81.71% | ๐บ๐ธ USA |